About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Detroit | 7,247 Studies Near You

Clinical TrialsDetroit

Clinical Trials in Detroit

Discover 7,247 clinical trials near Detroit, Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3961-3980 of 7,247 trials

CompletedA Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care TreatmentThis non-interventional study will prospectively collect detailed, high-quality documentation of bleeds, HRQoL, and safety in patients with hemophilia A with or without FVIII…NCT02476942·Santa Monica, California and 34 others

Find Trials by Condition in Detroit

Breast Cancerin Detroit Lung Cancerin Detroit Prostate Cancerin Detroit Colorectal Cancerin Detroit Melanomain Detroit Leukemiain Detroit Lymphomain Detroit Pancreatic Cancerin Detroit Ovarian Cancerin Detroit Brain Cancerin Detroit Diabetes

Data from ClinicalTrials.govTerms

TerminatedThe Chimerix CMX001 RegistryThe prospective observational study is to establish a registry database to evaluate the potential impact of prior treatment with CMX001 on the long-term incidence of specific…NCT02167685·La Jolla, California and 50 others

CompletedStudy Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast CancerThis study was designed to determine how effective and safe a new investigational drug, lapatinib, is in treating patients with treatment refractory or relapsed inflammatory…NCT00105950·Miami, Florida and 26 others

TerminatedStudy of Cilofexor in Adults With Primary Sclerosing CholangitisThe primary objective of this study is to evaluate whether cilofexor reduces the risk of fibrosis progression among non-cirrhotic adults with primary sclerosing cholangitis (PSC).NCT03890120·Glendale, Arizona and 200 others

CompletedBelimumab in Remission of VASculitisThe purpose of this study is to evaluate the efficacy and safety of belimumab, in combination with azathioprine, for the maintenance of remission following a standard induction…NCT01663623·Birmingham, Alabama and 88 others

RecruitingA Platform Study in Non-Small Cell Lung Cancer (NSCLC)The purpose of this study is to assess the safety and efficacy of multiple study interventions including novel-novel combinations or novel agents in combination with standard…NCT06996782·Phoenix, Arizona and 102 others

Active not recruitingP-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple MyelomaPhase 1 study comprised of open-label, dose escalation, multiple cohorts of P-BCMA-ALLO1 allogeneic T stem cell memory (Tscm) CAR-T cells in subjects with relapsed / refractory…NCT04960579·Goodyear, Arizona and 22 others

RecruitingAutologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerThis is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung cancerNCT04614103·Gilbert, Arizona and 70 others

CompletedZactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain TumorsPhase I: The purpose of this research study is to determine the safety of the combination treatment of ZD6474 (Vandetanib) with the standard therapy for glioblastomas and…NCT00441142·Boston, Massachusetts and 6 others

CompletedNP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor MalignanciesMulticenter, open-label study in patients with advanced or metastatic solid tumor malignancies to evaluate the safety, tolerability, and preliminary anti-tumor efficacy, PK, and…NCT05023486·Scottsdale, Arizona and 17 others

TerminatedA Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial HypertensionThis is a multi-center, open-label study of sitaxsentan sodium 100 mg taken orally once daily by subjects with PAH until sitaxsentan, in a particular country or region, is…NCT00811018·Birmingham, Alabama and 90 others

TerminatedAssessment of the WATCHMAN™ Device in Patients Unsuitable for Oral AnticoagulationThe purpose of this study is to establish the safety and effectiveness of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device, including the post-implant medication regimen…NCT02928497·Birmingham, Alabama and 91 others

CompletedStudy of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2aTwo LNF-containing regimens will be evaluated in the D-LIVR Phase 3 study: (1) LNF/RTV/PEG IFN-alfa-2a and (2) LNF/RTV.NCT03719313·Fresno, California and 115 others

Active not recruitingPragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled AsthmaThe goal of this study is to assess and compare the effectiveness of fluticasone furoate/umeclidinium bromide/vilanterol trifenatate (FF/UMEC/VI) with inhaled…NCT06372496·Centreville, Alabama and 116 others

CompletedA Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's DiseaseThis is a study to evaluate the effects of an investigational drug, Droxidopa, in participants with neurogenic orthostatic hypotension (NOH), associated with Parkinson's disease.NCT01176240·Alabaster, Alabama and 59 others

TerminatedPhosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart FailureThis study is a multi-center, prospective, randomized, double blind, placebo-controlled clinical trial.NCT01910389·Huntsville, Alabama and 62 others

CompletedBendamustine and Dexamethasone in Patients With Relapsed AL AmyloidosisThe study is being done to see if the combination of bendamustine and dexamethasone will help people with amyloidosis that has returned after standard treatment, and to to…NCT01222260·Boston, Massachusetts and 5 others

CompletedMK-3475/BCG in High Risk Superficial Bladder CancerThis is a single center Phase I safety and efficacy study of MK-3475 therapy used in combination with bladder infused BCG treatment for patients, 18 years or older, with high risk…NCT02324582·Springfield, Illinois and 2 others

TerminatedPanobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic SyndromeCancer is the uncontrolled growth of human cells. The growth of normal human cells is controlled by multiple mechanisms.NCT02676323·Los Angeles, California and 6 others

TerminatedClinical Trial of Brentuximab Vedotin in Classical Hodgkin LymphomaThis trial will study two treatment combinations for classical Hodgkin lymphoma (cHL). This trial will find out if these two treatment combinations work to treat cHL.NCT03646123·Fountain Valley, California and 75 others

PreviousPage 199 of 363Next

in Detroit

Heart Diseasein Detroit